Research programme: islet cell transplant therapy - Islet Sciences

Drug Profile

Research programme: islet cell transplant therapy - Islet Sciences

Alternative Names: Encapsulated porcine islet cells - Islet Sciences; Islet cells encapsulated with ultra-pure algae membrane - Islet Sciences; Islet Sciences-P; ISLT-P; PTM therapy - Islet Sciences

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Islet Sciences
  • Class Cell therapies
  • Mechanism of Action Pancreatic beta cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Type 1 diabetes mellitus

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for research development in Type-1 diabetes mellitus in USA (Intra-abdominal, Injection)
  • 30 Sep 2014 Islet Sciences and BHV Pharma enter into a definitive merger agreement ,
  • 27 Jun 2013 Dr Jonathan Lakey (Islet Sciences) receives $US1.27 million in funding from Juvenile Diabetes Research Foundation to support development of innovative methods to treat Type 1 diabetes mellitus, including its islet cell transplantation therapy
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top